Picture of Atrys Health SA logo

ATRY — Atrys Health SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Atrys Health Buys Genetic and Genomic Diagnosis Laboratory in Spain

Oct 1 (Reuters) - Atrys Health SA  ATRY.MC :
    * SAYS BUYS INSTITUTO DE ESTUDIOS CELULARES Y MOLECULARES
(ICM), A
GENETIC AND GENOMIC DIAGNOSIS LABORATORY BASED IN SPAIN
    * SAYS INCORPORATES THE DEVELOPMENT OF DIAGNOSTIC SERVICES
OF
COVID-19 FROM SALIVA, WITH HIGH SENSITIVITY AND MINIMALLY
INVASIVE, WHICH FACILITATES MASSIVE USE
    * SAYS THE INTEGRATION OF ICM WILL PROVIDE WITH NEW GENETIC
PANELS
FOR CANCER DIAGNOSIS, CARDIOVASCULAR, NEUROLOGICAL AND RARE
DISEASES

Source text: https://bit.ly/34cpe5r
Further company coverage:  ATRY.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 65 71;))

Recent news on Atrys Health SA

See all news